[HTML][HTML] Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19

M Ackermann, SE Verleden, M Kuehnel… - … England Journal of …, 2020 - Mass Medical Soc
Background Progressive respiratory failure is the primary cause of death in the coronavirus
disease 2019 (Covid-19) pandemic. Despite widespread interest in the pathophysiology of …

Autopsy-based pulmonary and vascular pathology: pulmonary endotheliitis and multi-organ involvement in COVID-19 associated deaths

M Haberecker, EI Schwarz, P Steiger, K Frontzek… - Respiration, 2022 - karger.com
Background: Findings from autopsies have provided evidence on systemic microvascular
damage as one of the underlying mechanisms of Coronavirus disease 2019 (CO-VID-19) …

Lung epithelial and endothelial damage, loss of tissue repair, inhibition of fibrinolysis, and cellular senescence in fatal COVID-19

F D'Agnillo, KA Walters, Y Xiao, ZM Sheng… - Science Translational …, 2021 - science.org
Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), is characterized by respiratory distress, multiorgan …

[HTML][HTML] Tracking the time course of pathological patterns of lung injury in severe COVID-19

T Mauad, AN Duarte-Neto, LFF da Silva… - Respiratory …, 2021 - Springer
Background Pulmonary involvement in COVID-19 is characterized pathologically by diffuse
alveolar damage (DAD) and thrombosis, leading to the clinical picture of Acute Respiratory …

[HTML][HTML] The pulmonary pathology of COVID-19

H Bösmüller, M Matter, F Fend, A Tzankov - Virchows Archiv, 2021 - Springer
The lung is the main affected organ in severe coronavirus disease 2019 (COVID-19) caused
by the novel coronavirus SARS-CoV-2, and lung damage is the leading cause of death in …

Novel insights on the pulmonary vascular consequences of COVID-19

F Potus, V Mai, M Lebret, S Malenfant… - … of Physiology-Lung …, 2020 - journals.physiology.org
In the last few months, the number of cases of a new coronavirus-related disease (COVID-
19) rose exponentially, reaching the status of a pandemic. Interestingly, early imaging …

COVID-19–associated lung microvascular endotheliopathy: a “from the bench” perspective

J Joffre, L Rodriguez, ZA Matthay, E Lloyd… - American Journal of …, 2022 - atsjournals.org
Rationale: Autopsy and biomarker studies suggest that endotheliopathy contributes to
coronavirus disease (COVID-19)-associated acute respiratory distress syndrome. However …

Pulmonary arterial thrombosis in COVID-19 with fatal outcome: results from a prospective, single-center, clinicopathologic case series

SF Lax, K Skok, P Zechner, HH Kessler… - Annals of internal …, 2020 - acpjournals.org
Background: Coronavirus disease 2019 (COVID-19) caused by the novel severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly become pandemic, with …

Pulmonary endothelial dysfunction and thrombotic complications in patients with COVID-19

C Rodríguez, N Luque, I Blanco… - American journal of …, 2021 - atsjournals.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a new strain of a
Coronaviridae virus that presents 79% genetic similarity to the severe acute respiratory …

[HTML][HTML] Pathology of lung‐specific thrombosis and inflammation in COVID‐19

RR Khismatullin, AA Ponomareva… - Journal of Thrombosis …, 2021 - Elsevier
Abstract Background Infection by SARS‐CoV‐2 produces significant pulmonary pathology
including endothelial damage with resultant thrombotic events. While pathologic features …